Lice Treatment Claims Require Tests On Humans, Not Just Bugs – NAD

NAD rejects TyraTech’s argument that because its Vamousse homeopathic works on lice and not people, non-human studies are adequate substantiation. Vamousse advertising referred to challenger Sanofi Pasteur’s Sklice prescription lice spray as less effective and more risky to human health.

TyraTech Inc. needs human clinical trials rather than in vitro tests to support claims that its Vamousse homeopathic formula kills all lice in one treatment, says the National Advertising Division.

The Council of Better Business Bureaus investigative unit rejected TyraTech’s argument that because its formula works on lice and not humans, non-human studies are relevant and adequate

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight